Banerjee S - Search Results

1

Neem leaf glycoprotein salvages T cell functions from Myeloid-derived suppressor cells-suppression by altering IL-10/STAT3 axis in melanoma tumor microenvironment.

Sarkar M, Bhuniya A, Ghosh S, Sarkar A, Saha A, Dasgupta S, Bera S, Chakravarti M, Dhar S, Guha I, Ganguly N, Das T, Banerjee S, Pal S, Ghosh SK, Bose A, Baral R. Sarkar M, et al. Among authors: banerjee s. Melanoma Res. 2021 Apr 1;31(2):130-139. doi: 10.1097/CMR.0000000000000721. Melanoma Res. 2021. PMID: 33625102

2

Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.

Chakraborty T, Bose A, Barik S, Goswami KK, Banerjee S, Goswami S, Ghosh D, Roy S, Chakraborty K, Sarkar K, Baral R. Chakraborty T, et al. Among authors: banerjee s. Immunotherapy. 2011 Aug;3(8):949-69. doi: 10.2217/imt.11.81. Immunotherapy. 2011. PMID: 21843083

3

Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: histological, biochemical and immunological perspectives.

Mallick A, Ghosh S, Banerjee S, Majumder S, Das A, Mondal B, Barik S, Goswami KK, Pal S, Laskar S, Sarkar K, Bose A, Baral R. Mallick A, et al. Among authors: banerjee s. Int Immunopharmacol. 2013 Jan;15(1):73-83. doi: 10.1016/j.intimp.2012.11.006. Epub 2012 Nov 21. Int Immunopharmacol. 2013. PMID: 23178577

4

Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma.

Mallick A, Barik S, Goswami KK, Banerjee S, Ghosh S, Sarkar K, Bose A, Baral R. Mallick A, et al. Among authors: banerjee s. PLoS One. 2013;8(1):e47434. doi: 10.1371/journal.pone.0047434. Epub 2013 Jan 11. PLoS One. 2013. PMID: 23326300 Free PMC article.

5

Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.

Roy S, Barik S, Banerjee S, Bhuniya A, Pal S, Basu P, Biswas J, Goswami S, Chakraborty T, Bose A, Baral R. Roy S, et al. Among authors: banerjee s. Hum Immunol. 2013 Aug;74(8):1015-23. doi: 10.1016/j.humimm.2013.04.022. Epub 2013 Apr 27. Hum Immunol. 2013. PMID: 23628394

6

Neem leaf glycoprotein is superior than cisplatin and sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment.

Barik S, Bhuniya A, Banerjee S, Das A, Sarkar M, Paul T, Ghosh T, Ghosh S, Roy S, Pal S, Bose A, Baral R. Barik S, et al. Among authors: banerjee s. Int Immunopharmacol. 2013 Sep;17(1):42-9. doi: 10.1016/j.intimp.2013.05.005. Epub 2013 Jun 5. Int Immunopharmacol. 2013. PMID: 23747315

7

Tumor-derived vascular pericytes anergize Th cells.

Bose A, Barik S, Banerjee S, Ghosh T, Mallick A, Bhattacharyya Majumdar S, Goswami KK, Bhuniya A, Banerjee S, Baral R, Storkus WJ, Dasgupta PS, Majumdar S. Bose A, et al. Among authors: banerjee s. J Immunol. 2013 Jul 15;191(2):971-81. doi: 10.4049/jimmunol.1300280. Epub 2013 Jun 19. J Immunol. 2013. PMID: 23785117

8

Normalization of tumor microenvironment by neem leaf glycoprotein potentiates effector T cell functions and therapeutically intervenes in the growth of mouse sarcoma.

Barik S, Banerjee S, Mallick A, Goswami KK, Roy S, Bose A, Baral R. Barik S, et al. Among authors: banerjee s. PLoS One. 2013 Jun 13;8(6):e66501. doi: 10.1371/journal.pone.0066501. Print 2013. PLoS One. 2013. PMID: 23785504 Free PMC article.

9

Supraglottic laryngeal tumor microenvironmental factors facilitate STAT3 dependent pro-tumorigenic switch in tumor associated macrophages to render utmost immune evasion.

Goswami KK, Barik S, Banerjee S, Bhowmick AK, Biswas J, Bose A, Baral R. Goswami KK, et al. Among authors: banerjee s. Immunol Lett. 2013 Nov-Dec;156(1-2):7-17. doi: 10.1016/j.imlet.2013.09.003. Epub 2013 Sep 9. Immunol Lett. 2013. PMID: 24029664

10

A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth.

Das A, Barik S, Banerjee S, Bose A, Sarkar K, Biswas J, Baral R, Pal S. Das A, et al. Among authors: banerjee s. J Immunother. 2014 Oct;37(8):394-406. doi: 10.1097/CJI.0000000000000050. J Immunother. 2014. PMID: 25198527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,880 results

Search Page